| Not Yet Recruiting | Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy NCT06976021 | Maria Sklodowska-Curie National Research Institute of Oncology | Phase 2 |
| Recruiting | Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes NCT06640283 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Not Yet Recruiting | A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening NCT06491888 | Lei Li | N/A |
| Not Yet Recruiting | A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection NCT06481930 | Lei Li | — |
| Recruiting | Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing i NCT06254846 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Not Yet Recruiting | Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immun NCT05824494 | Women's Hospital School Of Medicine Zhejiang University | Phase 2 |
| Enrolling By Invitation | Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening NCT05231993 | Karolinska Institutet | N/A |
| Completed | Three Birds With One Stone NCT05022511 | University of Aarhus | N/A |
| Unknown | Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer NCT04886700 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 2 |
| Unknown | Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV NCT04974424 | Huazhong University of Science and Technology | — |
| Active Not Recruiting | Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer NCT04516616 | Huazhong University of Science and Technology | Phase 2 |
| Recruiting | Detecting HPV DNA in Anal and Cervical Cancers NCT04857528 | University of Chicago | — |
| Completed | Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors NCT03023319 | Nagla Abdel Karim | Phase 1 |
| Unknown | A Cohort Study for the Following up of Conization NCT03961178 | Lei Li | — |
| Unknown | DNA Methylation for Screening Uterine Cervical Lesions NCT03960879 | Lei Li | — |
| Unknown | DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study NCT03961191 | Lei Li | — |
| Completed | Adaptative Radiotherapy for Locally Advanced Cervical Cancer NCT02937948 | Center Eugene Marquis | N/A |
| Completed | Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients NCT03308591 | Huazhong University of Science and Technology | Phase 3 |
| Unknown | Specific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer NCT03229187 | Huazhong University of Science and Technology | — |
| Completed | Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL NCT02439034 | Centre Oscar Lambret | Phase 2 |
| Unknown | Adjuvant Chemotherapy for Locally Advanced Cervical Cancer NCT02036164 | Siriwan Tangjitgamol, MD | Phase 3 |
| Completed | A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients NCT01755897 | Huazhong University of Science and Technology | N/A |
| Completed | Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers NCT01523678 | Belgian Gynaecological Oncology Group | Phase 2 |
| Unknown | Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer NCT01667211 | Chinese Academy of Medical Sciences | Phase 2 |
| Terminated | FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer NCT02317302 | Washington University School of Medicine | Phase 1 |
| Unknown | Evaluation of Long-term HPV Vaccine Efficacy NCT01393470 | Tampere University | — |
| Terminated | To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Partic NCT01284348 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Community Awareness, Resources and Education (CARE II): Project 3 NCT01299714 | Ohio State University Comprehensive Cancer Center | — |
| Unknown | Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence NCT01226264 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Terminated | Intended Use Study of the BD SurePath Plus™ Pap NCT01234480 | Becton, Dickinson and Company | — |
| Terminated | Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Canc NCT00900562 | PharmaMar | Phase 2 |
| Completed | A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer NCT02095119 | National Institute of Cancerología | Phase 1 / Phase 2 |
| Terminated | Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer NCT00421096 | Centre Oscar Lambret | Phase 2 |
| Completed | Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix NCT00266084 | University Hospitals Cleveland Medical Center | — |
| Completed | Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cerv NCT00184093 | University of Southern California | Phase 1 / Phase 2 |